MA-DESKTOP-METAL
18.6.2024 14:31:33 CEST | Business Wire | Press release
Desktop Metal (NYSE: DM), a global leader in Additive Manufacturing 2.0 technologies for mass production, today announced that platinum is now a customer-qualified material on the Production System™ P-1 with a specialty powder developed by Legor.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240618795152/en/
Platinum jewelry designs 3D printed by Legor on a Desktop Metal Production System P-1 are slated to be part of a multi-material, multi-customer jewelry display featured by Desktop Metal at Rapid + TCT, North America’s largest additive manufacturing and industrial 3D printing event, to be held June 25-27 in Los Angeles. The Legor parts to be shown include including a classic wedding band, a gemstone ring, and an intricate leaf earring. (Photo: Business Wire)
Legor is a full-service jewelry manufacturing solutions provider, and the company’s Powmet line of certified ultra-pure metal powders is produced for use with both laser and binder jet 3D printing systems.
“The qualification of Legor’s Powmet platinum on the Production System P-1 is another major milestone for binder jet 3D printing for the jewelry, watchmaking, and luxury goods industry,” said Ric Fulop, Founder and CEO of Desktop Metal. “Platinum is known to be a challenging-to-process material in the jewelry industry because of its high hardness and melting point. Our binder jet 3D printing process simplifies platinum production and enables all-new, once-impossible designs.”
”Legor is currently experiencing significant market interest in 3D printing technology, specifically in binder jet technology,” added Fabio Di Falco, Marketing and Customer Support Manager at Legor. “This has led us to address a variety of requests, ranging from prototyping to small batch production, as well as larger production runs. Thanks to binder jet 3D printing technology, designers can finally imagine and create objects that are currently unproducible with other technologies, thus expanding the boundaries of creativity to shape the future. At Legor, we are committed to becoming catalysts for innovation and promoting technology we are convinced represents a crucial turning point for our industry.”
Platinum jewelry designs 3D printed by Legor — including a classic wedding band, a gemstone ring, and an intricate leaf earring — are slated to be part of a multi-material, multi-customer jewelry display featured by Desktop Metal at Rapid + TCT, North America’s largest additive manufacturing and industrial 3D printing event, to be held June 25-27 in Los Angeles.
Binder Jet 3D Printing for Jewelry and Watchmaking
In 2023, Legor invested in a Desktop Metal Production System P-1, a high-speed, 1-liter binder jet 3D printing system featuring Single Pass Jetting (SPJ) technology. The experienced jewelry manufacturer notes that binder jet 3D printing technology offers several benefits over traditional manufacturing methods and other forms of 3D printing for jewelry production including:
- Rapid production of jewelry samples without molds or printing supports
- All-new design freedom for fast, affordable production of hollow, interlinked, intricate, and mass customized designs
- Elimination of processing steps associated with jewelry designs, such as welding
- Simplified production of materials that are difficult to work with, such as platinum, which often requires special tools
- Low waste production that is eco-friendly and uses only the necessary amount of metal needed to create the design
Legor’s Di Falco noted that sustainability is an important feature of binder jet 3D printing technology for the jewelry industry and Legor specifically.
“Binder jet 3D printing technology represents a significant step toward more sustainable production,” he noted, “enabling energy efficiency, and reducing the amount of material used. Indeed, binder jetting uses exactly the amount of material necessary to create an object, drastically reducing waste. The metal powder not used in the process can be reused, reducing the need for new raw materials and the risks associated with metal extraction. At Legor, we advocate for 3D printing as a responsible production approach that also considers the planet and people.”
A video by Legor showing the benefits of binder jetting platinum jewelry can be viewed at https://legor.com/en/prodotto/platinum-3d-printing/.
For more information about binder jetting jewelry with DM technologies, visit TeamDM.com/jewelry.
About Desktop Metal
Desktop Metal (NYSE:DM) is driving Additive Manufacturing 2.0, a new era of on-demand, digital mass production of industrial, medical, and consumer products. Our innovative 3D printers, materials, and software deliver the speed, cost, and part quality required for this transformation. We’re the original inventors and world leaders of the 3D printing methods we believe will empower this shift, binder jetting and digital light processing. Today, our systems print metal, polymer, sand and other ceramics, as well as foam and recycled wood. Manufacturers use our technology worldwide to save time and money, reduce waste, increase flexibility, and produce designs that solve the world’s toughest problems and enable once-impossible innovations. Learn more about Desktop Metal and our #TeamDM brands at www.desktopmetal.com.
Forward-looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical facts contained in these communications, including statements regarding Desktop Metal’s future results of operations and financial position, financial targets, business strategy, and plans and objectives for future operations, are forward-looking statements. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to: risks associated with the integration of the business and operations of acquired businesses; Desktop Metals’ ability to realize the benefits from cost saving measures; supply and logistics disruptions, including shortages and delays. For more information about risks and uncertainties that may impact Desktop Metal’s business, financial condition, results of operations and prospects generally, please refer to Desktop Metal’s reports filed with the SEC, including without limitation the “Risk Factors” and/or other information included in the Form 10-Q filed with the SEC on August 3, 2023, and such other reports as Desktop Metal has filed or may file with the SEC from time to time. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240618795152/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
